Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Exelixis Inc (EXEL)

Exelixis Inc (EXEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May Business Wire - Thu May 7, 3:05PM CDT

- Presentations to be webcast on www.exelixis.com -

EXEL : 48.16 (+4.22%)
Exelixis: Q1 Earnings Snapshot AP - Tue May 5, 3:13PM CDT

Exelixis: Q1 Earnings Snapshot

EXEL : 48.16 (+4.22%)
Exelixis Announces First Quarter 2026 Financial Results and Provides Corporate Update Business Wire - Tue May 5, 3:05PM CDT

- Total Revenues of $610.8 million, Cabozantinib Franchise U.S. Net Product Revenues of $555.0 million - - GAAP Diluted...

EXEL : 48.16 (+4.22%)
Exelixis Reports Tomorrow With Competitive Questions It Has Not Yet Answered Barchart - Mon May 4, 4:11PM CDT

Barchart Research What to Expect from EXEL Earnings EXEL Generated May 4, 2026 Current Price $44.17 EPS Estimate $$0.67 Consensus Rating Moderate Buy Average Move 9.60% Exelixis Reports Tomorrow With Competitive...

EXEL : 48.16 (+4.22%)
Exelixis to Release First Quarter 2026 Financial Results on Tuesday, May 5, 2026 Business Wire - Tue Apr 21, 3:05PM CDT

– Conference Call and Webcast to Follow at 5:00 p.m. ET / 2:00 p.m. PT –

EXEL : 48.16 (+4.22%)
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March Business Wire - Tue Feb 24, 3:05PM CST

- Presentations to be webcast on www.exelixis.com -

EXEL : 48.16 (+4.22%)
MarketBeat.com
Exelixis Reports Solid Earnings—Are New Highs Back on the Table? MarketBeat - Thu Feb 12, 11:40AM CST

Exelixis beats earnings estimates as Cabometyx drives profits and zanzalintinib positions the biotech for a major oncology expansion

EXEL : 48.16 (+4.22%)
Exelixis: Q4 Earnings Snapshot AP - Tue Feb 10, 3:22PM CST

Exelixis: Q4 Earnings Snapshot

EXEL : 48.16 (+4.22%)
Exelixis Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update Business Wire - Tue Feb 10, 3:05PM CST

– Total Revenues of $599 million for the Fourth Quarter of 2025, $2.320 billion for the Fiscal Year 2025 – – ...

EXEL : 48.16 (+4.22%)
Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint Inhibitor for Patients with Metastatic Colorectal Cancer Business Wire - Mon Feb 2, 7:00AM CST

– The FDA assigned a Prescription Drug User Fee Act target action date of December 3, 2026 – – Application is based on results...

EXEL : 48.16 (+4.22%)

Barchart Exclusives

CPI, Trump-Xi Meeting and Other Can't Miss Items this Week Barchart - 1 hour ago
Markets enter a potentially pivotal week as geopolitical developments dominate with both U.S.-Iran negotiations and a highly anticipated Trump-Xi summit creating binary outcomes that could dramatically shift market dynamics. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.